Wockhardt
₹2,084
- Market Cap
- ₹31,731Cr.
- P/E Ratio
- 79.6
- P/B Ratio
- 6.86
- EPS (TTM)
- ₹26.18
- Div Yield
- 0%
- ROCE
- 7.55%
- ROE
- 6.11%
52W Low: ₹1,08752W High: ₹2,422
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 8.0% a year over three years.
- Debt is 0.45× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Wockhardt — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 79.6P/E: 79.6 | P/B: 6.86Growth
ModestSales CAGR — 3Y: 8% · 1Y: 18%Profitability
Low MarginROCE: 7.55% | ROE: 6.11%Key Metrics
Valuation
PEG Ratio 1.85
Price / Sales 8.90x
Price / FCF 417.5x
Book Value ₹304
Margins & returns
Operating Margin 22%
Net Margin 11.6%
Return on Assets 4.8%